MorphoSys AG Q4 2022 Earnings Call Transcript
Slightly above 67% of MorphoSys' investor base is looking to short. The analysis of current outlook of investing in MorphoSys AG ADR suggests that many traders are alarmed regarding MorphoSys' prospects. MorphoSys' investing sentiment overview a quick insight into current market opportunities from investing in MorphoSys AG ADR. Many technical investors use MorphoSys AG ADR stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
MorphoSys |
Julia Neugebauer Ladies and gentlemen, good afternoon and good morning.
Read at insidermonkey.com
 |
MorphoSys Fundamental Analysis
We analyze MorphoSys' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of MorphoSys using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of MorphoSys based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Net Income
Net Income Comparative Analysis
MorphoSys is currently under evaluation in net income category among its peers. Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.
MorphoSys AG ADR Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with MorphoSys stock to make a market-neutral strategy. Peer analysis of MorphoSys could also be used in its relative valuation, which is a method of valuing MorphoSys by comparing valuation metrics with similar companies.
Peers
MorphoSys Related Equities
| NVCT | Nuvectis Pharma | 5.25 | ||||
| IMRX | Immuneering Corp | 2.27 | ||||
| IMCR | Immunocore Holdings | 1.62 | ||||
| PMVP | Pmv Pharmaceuticals | 1.34 | ||||
| IPSC | Century Therapeutics | 0.97 | ||||
| GOSS | Gossamer Bio | 0.56 | ||||
| ELVN | Enliven Therapeutics | 0.49 | ||||
| KRON | Kronos Bio | 0 | ||||
| RLYB | Rallybio Corp | 0 | ||||
| CGEM | Cullinan Oncology | 0.16 | ||||
| PCVX | Vaxcyte | 0.16 | ||||
| GBIO | Generation Bio | 0.93 | ||||
| CCCC | C4 Therapeutics | 1.10 | ||||
| GLUE | Monte Rosa | 1.14 | ||||
| EWTX | Edgewise Therapeutics | 1.33 | ||||
| MRSN | Mersana Therapeutics | 1.40 | ||||
| MLYS | Mineralys Therapeutics, | 1.68 | ||||
| REPL | Replimune | 1.78 | ||||
| VTYX | Ventyx Biosciences | 1.79 | ||||
| LYRA | Lyra Therapeutics | 1.90 | ||||
| ACLX | Arcellx | 2.12 |
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Other Consideration for investing in MorphoSys Stock
If you are still planning to invest in MorphoSys AG ADR check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the MorphoSys' history and understand the potential risks before investing.
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Equity Valuation Check real value of public entities based on technical and fundamental data |